So much power. They dialed it back for the first 12 patients in Phase 2 pivotal. Now they are getting the full dose in Phase 2 PIVOTAL!       $TLTFF   67 % CR IN PHASE ONE STUDY FROM ONE TREATMENT.   Check out this ride.